U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C14H15F2N3S.ClH.H2O
Molecular Weight 349.827
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEPICASTAT HYDROCHLORIDE

SMILES

O.Cl.NCC1=CNC(=S)N1[C@H]2CCC3=C(C2)C=C(F)C=C3F

InChI

InChIKey=AILBEJJAAWNNIR-XRIOVQLTSA-N
InChI=1S/C14H15F2N3S.ClH.H2O/c15-9-3-8-4-10(1-2-12(8)13(16)5-9)19-11(6-17)7-18-14(19)20;;/h3,5,7,10H,1-2,4,6,17H2,(H,18,20);1H;1H2/t10-;;/m0../s1

HIDE SMILES / InChI

Molecular Formula C14H15F2N3S
Molecular Weight 295.351
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/25602710 https://www.ncbi.nlm.nih.gov/pubmed/24983834

Nepicastat (SYN-117) is a potent and selective inhibitor of dopamine-β-hydroxylase. This compound in Phase 2 of clinical trial for the treatment cocaine addiction and posttraumatic stress disorder.

CNS Activity

Curator's Comment: Nepicastat is direct, competitive inhibitor of DBH that does not chelate copper, can cross the blood–brain barrier

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
9.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Doses

Doses

DosePopulationAdverse events​
160 mg 1 times / day multiple, oral
Dose: 160 mg, 1 times / day
Route: oral
Route: multiple
Dose: 160 mg, 1 times / day
Co-administed with::
сocaine
Sources: Page: p.8
unhealthy, ADULT
n = 13
Health Status: unhealthy
Condition: cocaine abuse
Age Group: ADULT
Sex: M+F
Food Status: UNKNOWN
Population Size: 13
Sources: Page: p.8
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.
2010 Nov

Sample Use Guides

In Vivo Use Guide
Curator's Comment: https://clinicaltrials.gov/ct2/show/NCT01704196?term=NEPICASTAT&rank=3
Post Traumatic Stress Disorder: 120 mg/day Cocaine Dependence: Nepicastat 120 mg and 100 mg riboflavin (once per day) for 11 weeks
Route of Administration: Oral
In Vitro Use Guide
Nepicastat produced concentration-dependent inhibition of bovine and human dopamine-beta-hydroxylase activity. The calculated IC50s for nepicastat were 8.5+0.8 nM and 9.0+0.8 nM for the bovine and human enzyme, respectively.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:28:03 GMT 2023
Edited
by admin
on Fri Dec 15 16:28:03 GMT 2023
Record UNII
VJ9868NW5X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NEPICASTAT HYDROCHLORIDE
USAN  
USAN  
Official Name English
NEPICASTAT HYDROCHLORIDE MONOHYDRATE
Common Name English
2H-IMIDAZOLE-2-THIONE, 5-(AMINOMETHYL)-1-(5,7-DIFLUORO-1,2,3,4-TETRAHYDRO-2-NAPHTHALENYL)-1,3-DIHYDRO-, MONOHYDROCHLORIDE, MONOHYDRATE, (S)-
Common Name English
NEPICASTAT HYDROCHLORIDE [USAN]
Common Name English
(S)-5-(AMINOMETHYL)-1-(5,7-DIFLUORO-1,2,3,4-TETRAHYDRO-2-NAPHTHALENYL)-1,3-DIHYDRO-2H-IMIDAZOLE-2-THIONE MONOHYDROCHLORIDE, MONOHYDRATE
Systematic Name English
5-(Aminomethyl)-1-[(S)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthyl]-4-imidazoline-2-thione monohydrochloride, monohydrate
Systematic Name English
RS-25560-197
Code English
Classification Tree Code System Code
NCI_THESAURUS C471
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
Code System Code Type Description
MESH
C109487
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
PUBCHEM
11954368
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
ChEMBL
CHEMBL1188395
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
EPA CompTox
DTXSID30938968
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
CAS
177645-08-8
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
FDA UNII
VJ9868NW5X
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
NCI_THESAURUS
C84004
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
CHEBI
139334
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
USAN
II-85
Created by admin on Fri Dec 15 16:28:03 GMT 2023 , Edited by admin on Fri Dec 15 16:28:03 GMT 2023
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY